Telix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.28-$12.48 |
Market Cap | $3.8B |
Shares Short | 244,900 |
Financials
See moreRevenue (12 Mos) | $890.7M |
Revenue Growth (YoY) | 22.3% |
Gross Profit (12 Mos) | $423.7M |
Diluted EPS | $0.10 |
News
See moreYahoo Finance • yesterday
Telix Pharmaceuticals Stock Leads 3 Fast Growing Insider Owned Shares
Yahoo Finance • last month
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
Yahoo Finance • last month
Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Business
Yahoo Finance • last month
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer
About
CEO | Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., Ph.D |
Address | 55 Flemington Road, North Melbourne, VIC, Australia, 3051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,120 |